Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD69 | Q07108 | 1/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 6/20 | 0.42 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.42 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.39 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.39 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.38 |
| ▸ | PYGB | P11216 | 1/20 | 0.36 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.36 |
| ▸ | SELL | P14151 | 1/20 | 0.36 |
| ▸ | SELP | P16109 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12236900 | 1.00 | CD69 (0.44) | CD69LGALS3LGALS8LGALS4MAPK1 | |
| SCHEMBL17131368 | 1.00 | CD69 (0.44) | CD69LGALS3LGALS8LGALS4MAPK1 | |
| SCHEMBL18022304 | 0.90 | CD69 (0.47) | CD69LGALS3LGALS8LGALS4MAPK1 | |
| SCHEMBL23491004 | 0.89 | CD69 (0.49) | CD69LGALS3LGALS8LGALS4MAPK1 | |
| SCHEMBL13895616 | 0.89 | CD69 (0.49) | CD69LGALS3LGALS8LGALS4MAPK1 | |
| SCHEMBL2602688 | 0.83 | LGALS3 (0.49) | CD69LGALS3LGALS8LGALS4MAPK1 | |
| SCHEMBL14091725 | 0.82 | LGALS3 (0.47) | CD69LGALS3LGALS8LGALS4MAPK1 | |
| SCHEMBL18589695 | 0.82 | LGALS3 (0.47) | CD69LGALS3LGALS8LGALS4MAPK1 | |
| SCHEMBL16745289 | 0.82 | MAPK1 (0.41) | CD69LGALS3LGALS8LGALS4MAPK1 | |
| SCHEMBL12694356 | 0.81 | LGALS3 (0.58) | CD69LGALS3LGALS8LGALS4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9849073-B2 | Deuterium-enriched hyaluronan | DEUTERIA BIOMATERIALS, LLC (US) | 2017-12-26 | — | — | US | disclosed |
| US-9662422-B2 | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation | ALLERGAN, INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-20150064147-A1 | CROSSLINKED HYALURONIC ACID-COLLAGEN GELS FOR IMPROVING TISSUE GRAFT VIABILITY AND SOFT TISSUE AUGMENTATION | ALLERGAN, INC. (US) | 2015-03-05 | — | — | US | disclosed |
| US-20130116411-A1 | METHODS OF MAKING HYALURONIC ACID/COLLAGEN COMPOSITIONS | ALLERGAN, INC. (US) | 2013-05-09 | — | — | US | disclosed |